Univercells boosted by EUR 20m European financing to accelerate the delivery of its vaccine portfolio

October 3rd 2019

EIB to lend EUR 20 million to the innovative Belgian biotechnology company, supported by the “InnovFin – EU-finance for innovators” programme. Financing to support Univercells’ R&D investments to develop four essential and undersupplied global health vaccines to be produced at affordable prices, high quality and large volumes.  Please find the press release here.